Ifp Advisors, Inc Century Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 6 shares of IPSC stock, worth $3. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6Holding current value
$3% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
72Shares Held
27.4MCall Options Held
12.1KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.46 Million0.87% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$2.06 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.85 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.6 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.52 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $37.7M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...